Persistence of chromosomal abnormalities additional to the Philadelphia chromosome after Philadelphia chromosome disappearance during imatinib therapy for chronic myeloid leukemia. [electronic resource]
Producer: 20070809Description: 564-5 p. digitalISSN:- 1592-8721
- Adult
- Aged
- Aged, 80 and over
- Aneuploidy
- Antineoplastic Agents -- therapeutic use
- Benzamides
- Chromosome Aberrations
- Chromosome Deletion
- Clone Cells -- pathology
- Drug Resistance, Neoplasm
- Female
- Humans
- Imatinib Mesylate
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- blood
- Male
- Monosomy
- Neoplastic Cells, Circulating
- Philadelphia Chromosome
- Piperazines -- therapeutic use
- Prognosis
- Pyrimidines -- therapeutic use
- Remission Induction
- Trisomy
No physical items for this record
Publication Type: Letter; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.